Milrinone Lactate Injection, Solution
Product Images NDC 0409-0212

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Milrinone Lactate (NDC 0409-0212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Milrinone Lactate (Milrinone 01)

Chemical structure of milrinone lactate, showing its molecular framework including a pyridine and a substituted pyridone ring, along with the lactate moiety represented by CH3CHOHCOOH.*

FDA Label Image

Logo (Milrinone 01a)

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Label for Milrinone Lactate Injection 10 mg per 10 mL (1 mg/mL) single-dose vial for intravenous use. The label indicates the product is prescription only, manufactured by Gland Pharma Limited for Hospira, Inc., with storage instructions and formulation details including pH adjustment and absence of preservatives.*

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Packaging label for Milrinone Lactate Injection, 1 mg/mL (10 mg/10 mL) intravenous solution by Hospira, Inc. The label features a yellow band with the product name prominently displayed. It indicates the product is supplied in single-dose vials, with a package containing 10 vials of 10 mL each. The label includes storage instructions, product description, NDC numbers, and manufacturer details, along with a barcode area and Hospira logo.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Label for Milrinone Lactate Injection, 1 mg/mL (20 mg/20 mL), a single-dose vial for intravenous use. Manufactured for Hospira, Inc. The label includes storage instructions and ingredient details, mentioning a pH adjusted between 3.2 and 4.0, with no preservatives. The vial size is 20 mL.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Packaging label for Milrinone Lactate Injection 1 mg/mL, provided as 20 mg/20 mL single-dose vials. The label indicates it is for intravenous use only and includes details that it is manufactured by Hospira, Inc. The label also shows a batch barcode area and storage instructions.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Milrinone Lactate Injection 1 mg/mL solution label for intravenous use. The label indicates a 50 mL single-dose vial with a concentration of 50 mg per 50 mL. Manufactured by Hospira, Inc. The label includes storage instructions, dosage form, and barcode with lot and expiration fields.*

FDA Label Image

Principal Display Panel (50 mL Vial Carton)

Packaging label for Milrinone Lactate Injection 50 mg/50 mL (1 mg/mL) single-dose vial. The product is for intravenous use only, labeled with Hospira, Inc. as the manufacturer. The label includes storage instructions, formulation details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.